EP3171941 - N-METHYL-D-ASPARTATE RECEPTOR MODULATORS AND METHODS OF MAKING AND USING SAME [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 04.02.2022 Database last updated on 15.06.2024 | |
Former | The patent has been granted Status updated on 19.02.2021 | ||
Former | Grant of patent is intended Status updated on 28.06.2020 | ||
Former | Examination is in progress Status updated on 29.10.2019 | ||
Former | Request for examination was made Status updated on 28.04.2017 | ||
Former | The international publication has been made Status updated on 20.01.2017 | Most recent event Tooltip | 27.04.2024 | Lapse of the patent in a contracting state New state(s): MK | published on 29.05.2024 [2024/22] | Applicant(s) | For all designated states Naurex Inc. 1801 Maple Avenue, Suite 4300 Evanston, Illinois 60201 / US | [2017/22] | Inventor(s) | 01 /
KHAN, M. Amin 720 Oakton Street 3A Evanston, IL 60202 / US | [2017/22] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2017/22] | Application number, filing date | 15824872.4 | 24.07.2015 | [2017/22] | WO2015US42070 | Priority number, date | US201462028512P | 24.07.2014 Original published format: US 201462028512 P | US201562129388P | 06.03.2015 Original published format: US 201562129388 P | [2017/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016014982 | Date: | 28.01.2016 | Language: | EN | [2016/04] | Type: | A1 Application with search report | No.: | EP3171941 | Date: | 31.05.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.01.2016 takes the place of the publication of the European patent application. | [2017/22] | Type: | B1 Patent specification | No.: | EP3171941 | Date: | 24.03.2021 | Language: | EN | [2021/12] | Search report(s) | International search report - published on: | US | 28.01.2016 | (Supplementary) European search report - dispatched on: | EP | 16.02.2018 | Classification | IPC: | C07K5/103, A61K38/07, A61P25/00, A61P25/28 | [2020/29] | CPC: |
C07K5/1013 (EP,US);
A61K9/0019 (US);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/08 (EP);
A61P25/14 (EP);
A61P25/18 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P25/32 (EP);
A61P25/34 (EP);
A61P25/36 (EP);
A61P27/02 (EP);
A61P27/06 (EP);
A61P43/00 (EP);
A61P9/10 (EP);
C07K5/0823 (US);
A61K38/00 (EP,US)
(-)
|
Former IPC [2018/12] | C07K5/103, A61P25/28, A61K38/07 | ||
Former IPC [2017/22] | A61P25/28, A61K38/07 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/22] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | Title | German: | N-METHYL-D-ASPARTATREZEPTORMODULATOREN UND VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON | [2017/22] | English: | N-METHYL-D-ASPARTATE RECEPTOR MODULATORS AND METHODS OF MAKING AND USING SAME | [2017/22] | French: | MODULATEURS DU RÉCEPTEUR DE N-MÉTHYL-D-ASPARTATE ET LEURS PROCÉDÉS D'ÉLABORATION ET D'UTILISATION | [2017/22] | Entry into regional phase | 20.01.2017 | National basic fee paid | 20.01.2017 | Search fee paid | 20.01.2017 | Designation fee(s) paid | 20.01.2017 | Examination fee paid | Examination procedure | 20.01.2017 | Examination requested [2017/22] | 20.01.2017 | Date on which the examining division has become responsible | 17.09.2018 | Amendment by applicant (claims and/or description) | 04.11.2019 | Despatch of a communication from the examining division (Time limit: M04) | 12.03.2020 | Reply to a communication from the examining division | 29.06.2020 | Communication of intention to grant the patent | 01.12.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 09.02.2021 | Fee for grant paid | 09.02.2021 | Fee for publishing/printing paid | 09.02.2021 | Receipt of the translation of the claim(s) | Divisional application(s) | EP21164642.7 / EP3916003 | Opposition(s) | 04.01.2022 | No opposition filed within time limit [2022/10] | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 09.02.2021 | Request for further processing filed | 09.02.2021 | Full payment received (date of receipt of payment) Request granted | 18.02.2021 | Decision despatched | Fees paid | Renewal fee | 27.07.2017 | Renewal fee patent year 03 | 27.07.2018 | Renewal fee patent year 04 | 29.07.2019 | Renewal fee patent year 05 | 27.07.2020 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 24.07.2015 | AL | 24.03.2021 | AT | 24.03.2021 | CY | 24.03.2021 | CZ | 24.03.2021 | DK | 24.03.2021 | EE | 24.03.2021 | ES | 24.03.2021 | FI | 24.03.2021 | HR | 24.03.2021 | IT | 24.03.2021 | LT | 24.03.2021 | LV | 24.03.2021 | MC | 24.03.2021 | MK | 24.03.2021 | NL | 24.03.2021 | PL | 24.03.2021 | RO | 24.03.2021 | RS | 24.03.2021 | SE | 24.03.2021 | SI | 24.03.2021 | SK | 24.03.2021 | SM | 24.03.2021 | BG | 24.06.2021 | NO | 24.06.2021 | GR | 25.06.2021 | GB | 24.07.2021 | IE | 24.07.2021 | IS | 24.07.2021 | LU | 24.07.2021 | PT | 26.07.2021 | BE | 31.07.2021 | CH | 31.07.2021 | FR | 31.07.2021 | LI | 31.07.2021 | [2024/22] |
Former [2023/30] | HU | 24.07.2015 | |
AL | 24.03.2021 | ||
AT | 24.03.2021 | ||
CY | 24.03.2021 | ||
CZ | 24.03.2021 | ||
DK | 24.03.2021 | ||
EE | 24.03.2021 | ||
ES | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
IT | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
MC | 24.03.2021 | ||
NL | 24.03.2021 | ||
PL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SI | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
GB | 24.07.2021 | ||
IE | 24.07.2021 | ||
IS | 24.07.2021 | ||
LU | 24.07.2021 | ||
PT | 26.07.2021 | ||
BE | 31.07.2021 | ||
CH | 31.07.2021 | ||
FR | 31.07.2021 | ||
LI | 31.07.2021 | ||
Former [2023/29] | HU | 24.07.2015 | |
AL | 24.03.2021 | ||
AT | 24.03.2021 | ||
CZ | 24.03.2021 | ||
DK | 24.03.2021 | ||
EE | 24.03.2021 | ||
ES | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
IT | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
MC | 24.03.2021 | ||
NL | 24.03.2021 | ||
PL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SI | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
GB | 24.07.2021 | ||
IE | 24.07.2021 | ||
IS | 24.07.2021 | ||
LU | 24.07.2021 | ||
PT | 26.07.2021 | ||
BE | 31.07.2021 | ||
CH | 31.07.2021 | ||
FR | 31.07.2021 | ||
LI | 31.07.2021 | ||
Former [2023/10] | AL | 24.03.2021 | |
AT | 24.03.2021 | ||
CZ | 24.03.2021 | ||
DK | 24.03.2021 | ||
EE | 24.03.2021 | ||
ES | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
IT | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
MC | 24.03.2021 | ||
NL | 24.03.2021 | ||
PL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SI | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
GB | 24.07.2021 | ||
IE | 24.07.2021 | ||
IS | 24.07.2021 | ||
LU | 24.07.2021 | ||
PT | 26.07.2021 | ||
BE | 31.07.2021 | ||
CH | 31.07.2021 | ||
FR | 31.07.2021 | ||
LI | 31.07.2021 | ||
Former [2022/35] | AL | 24.03.2021 | |
AT | 24.03.2021 | ||
CZ | 24.03.2021 | ||
DK | 24.03.2021 | ||
EE | 24.03.2021 | ||
ES | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
MC | 24.03.2021 | ||
NL | 24.03.2021 | ||
PL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SI | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
GB | 24.07.2021 | ||
IE | 24.07.2021 | ||
IS | 24.07.2021 | ||
LU | 24.07.2021 | ||
PT | 26.07.2021 | ||
BE | 31.07.2021 | ||
CH | 31.07.2021 | ||
FR | 31.07.2021 | ||
LI | 31.07.2021 | ||
Former [2022/34] | AL | 24.03.2021 | |
AT | 24.03.2021 | ||
CZ | 24.03.2021 | ||
DK | 24.03.2021 | ||
EE | 24.03.2021 | ||
ES | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
MC | 24.03.2021 | ||
NL | 24.03.2021 | ||
PL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SI | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
GB | 24.07.2021 | ||
IS | 24.07.2021 | ||
LU | 24.07.2021 | ||
PT | 26.07.2021 | ||
BE | 31.07.2021 | ||
CH | 31.07.2021 | ||
FR | 31.07.2021 | ||
LI | 31.07.2021 | ||
Former [2022/23] | AL | 24.03.2021 | |
AT | 24.03.2021 | ||
CZ | 24.03.2021 | ||
DK | 24.03.2021 | ||
EE | 24.03.2021 | ||
ES | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
MC | 24.03.2021 | ||
NL | 24.03.2021 | ||
PL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SI | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
GB | 24.07.2021 | ||
IS | 24.07.2021 | ||
LU | 24.07.2021 | ||
PT | 26.07.2021 | ||
CH | 31.07.2021 | ||
FR | 31.07.2021 | ||
LI | 31.07.2021 | ||
Former [2022/22] | AL | 24.03.2021 | |
AT | 24.03.2021 | ||
CZ | 24.03.2021 | ||
DK | 24.03.2021 | ||
EE | 24.03.2021 | ||
ES | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
MC | 24.03.2021 | ||
NL | 24.03.2021 | ||
PL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SI | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
GB | 24.07.2021 | ||
PT | 26.07.2021 | ||
CH | 31.07.2021 | ||
LI | 31.07.2021 | ||
IS | 24.12.2021 | ||
Former [2022/21] | AL | 24.03.2021 | |
AT | 24.03.2021 | ||
CZ | 24.03.2021 | ||
DK | 24.03.2021 | ||
EE | 24.03.2021 | ||
ES | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
MC | 24.03.2021 | ||
NL | 24.03.2021 | ||
PL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SI | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
PT | 26.07.2021 | ||
CH | 31.07.2021 | ||
LI | 31.07.2021 | ||
IS | 24.12.2021 | ||
Former [2022/18] | AL | 24.03.2021 | |
AT | 24.03.2021 | ||
CZ | 24.03.2021 | ||
DK | 24.03.2021 | ||
EE | 24.03.2021 | ||
ES | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
MC | 24.03.2021 | ||
NL | 24.03.2021 | ||
PL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SI | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
PT | 26.07.2021 | ||
IS | 24.12.2021 | ||
Former [2022/13] | AL | 24.03.2021 | |
AT | 24.03.2021 | ||
CZ | 24.03.2021 | ||
DK | 24.03.2021 | ||
EE | 24.03.2021 | ||
ES | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
NL | 24.03.2021 | ||
PL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SI | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
PT | 26.07.2021 | ||
IS | 24.12.2021 | ||
Former [2022/10] | AL | 24.03.2021 | |
AT | 24.03.2021 | ||
CZ | 24.03.2021 | ||
DK | 24.03.2021 | ||
EE | 24.03.2021 | ||
ES | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
NL | 24.03.2021 | ||
PL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
PT | 26.07.2021 | ||
IS | 24.12.2021 | ||
Former [2022/08] | AL | 24.03.2021 | |
AT | 24.03.2021 | ||
CZ | 24.03.2021 | ||
DK | 24.03.2021 | ||
EE | 24.03.2021 | ||
ES | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
NL | 24.03.2021 | ||
PL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
IS | 24.07.2021 | ||
PT | 26.07.2021 | ||
Former [2022/07] | AL | 24.03.2021 | |
AT | 24.03.2021 | ||
CZ | 24.03.2021 | ||
EE | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
NL | 24.03.2021 | ||
PL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
IS | 24.07.2021 | ||
PT | 26.07.2021 | ||
Former [2021/52] | AT | 24.03.2021 | |
CZ | 24.03.2021 | ||
EE | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
NL | 24.03.2021 | ||
PL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
IS | 24.07.2021 | ||
PT | 26.07.2021 | ||
Former [2021/51] | AT | 24.03.2021 | |
CZ | 24.03.2021 | ||
EE | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
NL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
IS | 24.07.2021 | ||
PT | 26.07.2021 | ||
Former [2021/50] | AT | 24.03.2021 | |
CZ | 24.03.2021 | ||
EE | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
NL | 24.03.2021 | ||
RO | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SK | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
PT | 26.07.2021 | ||
Former [2021/48] | AT | 24.03.2021 | |
CZ | 24.03.2021 | ||
EE | 24.03.2021 | ||
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
NL | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
Former [2021/46] | AT | 24.03.2021 | |
FI | 24.03.2021 | ||
HR | 24.03.2021 | ||
LT | 24.03.2021 | ||
LV | 24.03.2021 | ||
NL | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
SM | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
Former [2021/43] | FI | 24.03.2021 | |
HR | 24.03.2021 | ||
LV | 24.03.2021 | ||
NL | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
Former [2021/38] | FI | 24.03.2021 | |
HR | 24.03.2021 | ||
LV | 24.03.2021 | ||
RS | 24.03.2021 | ||
SE | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
Former [2021/37] | FI | 24.03.2021 | |
HR | 24.03.2021 | ||
LV | 24.03.2021 | ||
RS | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
Former [2021/36] | FI | 24.03.2021 | |
HR | 24.03.2021 | ||
BG | 24.06.2021 | ||
NO | 24.06.2021 | ||
GR | 25.06.2021 | ||
Former [2021/35] | FI | 24.03.2021 | |
HR | 24.03.2021 | ||
NO | 24.06.2021 | ||
Former [2021/33] | FI | 24.03.2021 | |
NO | 24.06.2021 | Documents cited: | Search | [XI]DE3618407 (BRANTL VICTOR DIPL CHEM DR MED [DE]) [X] 1,2,7-13 * column 6, line 3 * * column 6, lines 16-32 * * claims 1, 9 * [I] 14; | [X] - LEONARDO BALDASSARRE ET AL, "Discovery of novel RIP derivatives by alanine scanning for the treatment of S. aureus infections", MEDCHEMCOMM, United Kingdom, (20130515), vol. 4, no. 7, doi:10.1039/c3md00122a, ISSN 2040-2503, pages 1114 - 1117, XP055448718 [X] 1,2,7-11 * the whole document and especially the abstract, the conclusions and Figure 1 * DOI: http://dx.doi.org/10.1039/c3md00122a | International search | [Y]WO2007088099 (ONCOREG AB [SE], et al) [Y] 71-74, 75/72-74, 78-80, 81/78-80, 84 * ; claim 2 *; | [Y]WO2011003064 (NAUREX INC [US], et al) [Y] 2-6, 7/2-6, 8-13, 14/9-13, 15-19, 20/15-19 * ; paragraphs [0015], [0037], [0039] *; | [Y]US2011306586 (KHAN AMIN [US], et al) [Y] 1, 7/1, 39-40, 41/39-40 * ; paragraphs [0008]-[0010], [0014]-[0016] *; | [A]US2012004309 (KHAN AMIN [US], et al) [A] 1-6, 7/1-6, 8-13, 14/9-13, 15 -19, 20/15-19, 39-40, 41/39 -40, 46-47, 48/46-47, 49/48 /46-47, 50/48/46-47, 54/46 -47, 55/54/46-47, 56/54/46 -47, 60/46-47, 71-74, 75/72 -74, 78-80, 81/78-80, 84* ; entire document *; | [XY]US2013035292 (MOSKAL JOSEPH [US], et al) [X] 46-47, 48/46-47, 49/48/46-47, 50/48/46-47, 54/46-47, 55/54/46-47, 56/54/46-47, 60/46-47 * ; paragraphs [0028], [0037]-[0040], [0041], [0043], [0052], [0103] * [Y] 1-6, 7/1-6, 8-13, 14/9-13, 15-19, 20/15-19, 39-40, 41/39-40, 71-74, 75/72-74, 78-80, 81/78-80, 84 | by applicant | US2013035292 | - FOSTER et al., Nature, (19870000), vol. 329, pages 395 - 396 | - MAYER et al., Trends in Pharmacol. Sci., (19900000), vol. 11, pages 254 - 260 | - MOSKAL et al., "Review; The use of antibody engineering to create novel drugs that target N-methyl-D-aspartate receptors", Current Drug Targets, (20010000), vol. 2, no. 3, pages 331 - 45 | - URWYLER SFLOERSHEIM PROY BLKOLLER M, J Med Chem., (20090000), vol. 52, no. 16, pages 5093 - 107 |